Analysts expect Exagen Inc. to report revenue of 19.17 M for Q3 26, against a range of 18.05 M to 20.30 M. The most recent reported quarter, Q2 26, came in at 19.94 M, a 15.5% beat against the 17.27 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 12.51 M | 13.65 M | 15.50 M | 17.20 M | 17.24 M | 16.63 M | 17.31 M | 19.94 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 14.35 M | 15.81 M | 14.27 M | 16.82 M | 16.74 M | 18.21 M | 16.44 M | 18.00 M | 20.30 M | 17.71 M | 18.83 M | 20.68 M | 23.58 M | 23.14 M | 23.40 M | 24.31 M | ||||||||||
| Low Estimate | 12.02 M | 13.27 M | 13.07 M | 14.56 M | 14.99 M | 16.49 M | 15.06 M | 16.54 M | 18.05 M | 16.65 M | 17.16 M | 18.84 M | 20.41 M | 20.05 M | 20.21 M | 20.21 M | ||||||||||
| Consensus Estimate | 13.18 M | 14.54 M | 13.67 M | 15.69 M | 15.87 M | 17.35 M | 15.75 M | 17.27 M | 19.17 M | 17.18 M | 17.99 M | 19.76 M | 21.99 M | 21.60 M | 21.80 M | 22.26 M |
Analysts expect Exagen Inc. to report earnings per share of -0.19 for Q3 26, against a range of -0.20 to -0.18. The most recent reported quarter, Q2 26, came in at -0.13, a 31.6% beat against the -0.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.28 | -0.20 | -0.20 | -0.21 | -0.31 | -0.20 | -0.17 | -0.13 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.26 | -0.24 | -0.18 | -0.15 | -0.14 | -0.18 | -0.22 | -0.18 | -0.18 | -0.19 | -0.17 | -0.09 | -0.14 | -0.12 | -0.10 | -0.05 | ||||||||||
| Low Estimate | -0.28 | -0.26 | -0.22 | -0.17 | -0.18 | -0.22 | -0.26 | -0.20 | -0.20 | -0.21 | -0.19 | -0.11 | -0.16 | -0.14 | -0.12 | -0.05 | ||||||||||
| Consensus Estimate | -0.27 | -0.25 | -0.20 | -0.16 | -0.16 | -0.20 | -0.24 | -0.19 | -0.19 | -0.20 | -0.18 | -0.10 | -0.15 | -0.13 | -0.11 | -0.05 |
Pull Wall Street consensus for Exagen Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=XGN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "XGN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=XGN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();